REFERENCES
- Hogg J C, Chu F, Utokaparch S, Woods R, Elliott W M, Buzatu L, Cherniack R M, Rogers R M, Sciurba F C, Coxson H O, Pare P D. The nature of small-airway obstruction in chronic obstructive pulmonary disease. New Engl J Med 2004; 350: 2645–2653
- Fairclough L, Urbanowicz R A, Corne J, Lamb J R. Killer cells in chronic obstructive pulmonary disease. Clin Sci (Lond) 2008; 114: 533–541
- Roos-Engstrand E, Ekstrand-Hammarström B, Pourazar J, Behndig A F, Bucht A, Blomberg A. Influence of smoking cessation on airway T lymphocyte subsets in COPD. J COPD 2009; 6(2)112–120
- Rubtsov Y P, Rasmussen J P, Chi E Y, Fontenot J, Castelli L, Ye X, Treuting P, Siewe L, Roers A, Henderson W R, Jr, Muller W, Rudensky A Y. Regulatory T cell-derived interleukin-10 limits inflammation at environmental interfaces. Immunity 2008; 28: 546–558
- Zheng Y, Chaudhry A, Kas A, Deroos P, Kim J M, Chu T T, Corcoran L, Treuting P, Klein U, Rudensky A Y. Regulatory T-cell suppressor program co-opts transcription factor IRF4 to control T(H)2 responses. Nature 2009, [Epub ahead of print]
- Pasare C, Medzhitov R. Toll pathway-dependent blockade of CD4+CD25+ T cell-mediated suppression by dendritic cells. Science 2003; 299: 1033–1036
- Kohlmeier J E, Miller S C, Woodland D L. Cutting edge: Antigen is not required for the activation and maintenance of virus-specific memory CD8+ T cells in the lung airways. J Immunol 2007; 178: 4721–4725
- Barcelo B, Pons J, Ferrer J M, Sauleda J, Fuster A, Agusti A G. Phenotypic characterisation of T-lymphocytes in COPD: abnormal CD4+CD25+ regulatory T-lymphocyte response to tobacco smoking. Eur Respir J 2008; 31: 555–562
- Smyth L J, Starkey C, Vestbo J, Singh D. CD4-regulatory cells in COPD patients. Chest 2007; 132: 156–163
- Zheng Y, Rudensky A Y. Foxp3 in control of the regulatory T cell lineage. Nat Immunol 2007; 8: 457–462